# Bitherapy With the Combination of Raltegravir and Darunavir (BIRDi)

> **NCT03348449** · — · COMPLETED · sponsor: **Asociacion para el Estudio de las Enfermedades Infecciosas** · enrollment: 360 (actual)

## Conditions studied

- Comorbidities
- HIV/AIDS

## Interventions

- **OTHER:** Collection of data

## Key facts

- **NCT ID:** NCT03348449
- **Lead sponsor:** Asociacion para el Estudio de las Enfermedades Infecciosas
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-15
- **Primary completion:** 2018-06-15
- **Final completion:** 2018-06-29
- **Target enrollment:** 360 (ACTUAL)
- **Last updated:** 2018-07-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03348449

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03348449, "Bitherapy With the Combination of Raltegravir and Darunavir (BIRDi)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03348449. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*